ALEXANDER K. ARROW

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Protagenic Therapeutics, Inc.\new

Filing Date Source Excerpt
2016-05-03 On April 15, 2016, we made the following option grants under the 2016 Plan. These grants will become void if the 2016 Plan is not approved by our stockholders: Alexander Arrow: 140,000 options at $1.25/share, vesting over 36 months
2025-03-10 Alexander K. Arrow(1) 244,773(5) 5 % ... Alexander K. Arrow Chief Financial Officer

Data sourced from SEC filings. Last updated: 2026-03-05